Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
3.14 0.09  (2.95%)
TradingVolume：3317.2
03-14
2016
ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIAL FOR NEW DRUG GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) IN THE U.S.
Publisher：
03-04
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2016
Publisher：
02-03
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2016
Publisher：
01-05
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2015
Publisher：
12-30
2015
Terms of Reference for the Audit Committee of the board of directors of the Company
Publisher：
12-15
2015
ANNOUNCEMENT - COMPLETION OF TWO PHASE 1 CLINICAL STUDIES OF ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION (LY03003) IN THE U.S.
Publisher：
12-09
2015
ANNOUNCEMENT - ESTABLISHMENT OF A SUBSIDIARY
Publisher：
12-04
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2015
Publisher：
12-03
2015
ANNOUNCEMENT - APPROVAL FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR LEVETIRACETAM EXTENDED RELEASE TABLET
Publisher：
11-05
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2015
Publisher：
First
46
47
48
49
50
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：3317.2
3.14
0.09  (2.95%)
Announcement & Circular
03-14
2016
ANNOUNCEMENT - APPROVAL FOR CLINICAL TRIAL FOR NEW DRUG GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) IN THE U.S.
03-04
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2016
02-03
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2016
01-05
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2015
12-30
2015
Terms of Reference for the Audit Committee of the board of directors of the Company
12-15
2015
ANNOUNCEMENT - COMPLETION OF TWO PHASE 1 CLINICAL STUDIES OF ROTIGOTINE EXTENDED RELEASE MICROSPHERES FOR INJECTION (LY03003) IN THE U.S.
12-09
2015
ANNOUNCEMENT - ESTABLISHMENT OF A SUBSIDIARY
12-04
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2015
12-03
2015
ANNOUNCEMENT - APPROVAL FOR THE COMMENCEMENT OF CLINICAL TRIALS FOR LEVETIRACETAM EXTENDED RELEASE TABLET
11-05
2015
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2015
First
46
47
48
49
50
Last